Related Experiment Videos
[Tuberculosis in human immunodeficiency virus infection. 22 cases]
Summary
Tuberculosis in HIV-positive individuals in France presented with more lung cavities and later onset than in the US. Despite this, chemotherapy was effective, though AIDS complications led to mortality.
Area of Science:
- Infectious Diseases
- Public Health
- Immunology
Context:
- Retrospective analysis of 22 tuberculosis (TB) cases in HIV-1 positive patients in Marseille, France.
- High prevalence area for Human Immunodeficiency Virus (HIV) infection.
- Significant proportion of patients were intravenous drug users (67%) and had Acquired Immunodeficiency Syndrome (AIDS) prior to TB diagnosis (32%).
Purpose:
- To document and analyze the clinical presentation, treatment response, and outcomes of tuberculosis in HIV-1 positive patients in a specific French region.
- To compare findings with studies from other geographical areas, particularly the United States.
- To explore potential factors influencing observed epidemiological differences.
Summary:
- M. tuberculosis was isolated from bronchopulmonary samples in nearly all patients.
- Pulmonary tuberculosis frequently presented with excavated lesions (5/10 with radiological abnormalities).
- Extrathoracic involvement was infrequent (4 cervical adenopathies, 4 asymptomatic extra-pulmonary sites).
- All patients responded to chemotherapy with no relapses.
- Mortality was primarily due to AIDS complications within two years post-TB diagnosis.
Impact:
- Findings suggest unique epidemiological characteristics of TB in HIV-1 positive individuals in this French cohort.
- Observed differences in TB presentation (e.g., high frequency of excavated pulmonary lesions, later onset) may be influenced by local factors.
- Potential impact of childhood BCG vaccination on TB epidemiology in HIV-1 positive populations warrants further investigation.